IBT
ALLK

International Biotechnology Trust’s Allakos ALLK Stock Holding History

International Biotechnology Trust’s Portfolio ALLK Stock Details ALLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,700
Closed -$1.66M – 74
2021
Q3 		$1.66M Hold
15,700
– – 0.4% 43
2021
Q2 		$1.34M Hold
15,700
– – 0.35% 47
2021
Q1 		$1.8M Hold
15,700
– – 0.48% 34
2020
Q4 		$2.19M Hold
15,700
– – 0.6% 32
2020
Q3 		$1.28M Hold
15,700
– – 0.41% 37
2020
Q2 		$1.14M Hold
15,700
– – 0.38% 38
2020
Q1 		$692K Buy
+15,700
New +$1.07M 0.32% 45

Other funds holding ALLK

RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

International Biotechnology Trust's ALLK Position: Q4 2021 in Review

International Biotechnology Trust sold out of Allakos (ALLK) in Q4 2021, closing a stake of 15,700 shares — an estimated $1.66M sold.

International Biotechnology Trust first reported a position in ALLK in Q1 2020 and held it in 7 quarters. The position peaked at $2.19M in Q4 2020. 141 funds tracked by Wall St. Rank hold ALLK as of Q4 2021.

  • International Biotechnology Trust reported no remaining Allakos position as of Q4 2021 after selling out during the quarter.
  • International Biotechnology Trust sold 15,700 Allakos shares in Q4 2021, an estimated $1.66M.
  • International Biotechnology Trust first reported a position in Allakos in Q1 2020 and held it in 7 quarters.
  • International Biotechnology Trust's Allakos position peaked at $2.19M in Q4 2020.
  • 141 funds tracked by Wall St. Rank held Allakos as of Q4 2021.

Based on International Biotechnology Trust's 13F filing for Q4 2021, filed 15 Feb 2022.